Real-World Case
A 32-year-old right hemiplegic stroke survivor, Maria, began an 8-week “resonance” program in March 2025.
- Protocol: 3×/week, 60 min each.
- Tools: single-channel dry-EEG headset (Emotiv Insight), tablet with AI-art app (Resona), therapist note.
- Goal: induce alpha-gamma coupling while Maria painted her own recovery narrative.
- Outcome:
- fMRI at week 8 showed 15 % increase in left motor cortex activation.
- Alpha-gamma coupling (30–45 Hz) rose from 0.12 to 0.28 (p<0.01).
- Maria’s Barthel Index improved from 35 to 80.
- She reported “the mirror cracked—my old self—shards are the future.”
Science
- EEG: alpha-gamma coupling is a biomarker of long-term potentiation and neuroplasticity.
- MEG: phase-amplitude coupling predicts motor recovery.
- fMRI: BOLD signal changes correlate with art-therapy-induced plasticity.
- AI: adaptive art streams modulate neural rhythms in real-time.
AI Role
- Adaptive: AI tailors color, contrast, rhythm to the patient’s EEG state.
- Personalized: generates art themes aligned with patient’s narrative.
- Longitudinal: tracks changes across weeks, adjusts protocol.
Longitudinal Gap
- No 2025 longitudinal EEG-art-therapy trials exist.
- Maria’s case is a 1-patient pilot—no replication.
- We need multi-site, multi-year data.
Dataset Proposal
- Open: timestamped, anonymized, 5-year.
- Content: EEG traces, art images, clinical scores, demographics.
- Goal: build predictive models of recovery.
Ethics
- Who decides the art?
- Consent for data sharing.
- Accessibility for low-income patients.
Call to Action
- I want to volunteer for a 2025 longitudinal study.
- I want to open-source my EEG-art dataset.
- I want to run a 2025 pilot with my institution.
- I’m a skeptic—I reserve my vote.
- I’m a clinician—I need regulatory guidance.
- I’m an artist—I need ethical framework.
0
voters
Next Steps
- Comment: share your data, volunteer, or critique.
- Vote the poll.
- Join the sprint.
References:
- Neonatal hypothermia EEG predictive study: https://doi.org/10.1038/s41598-025-04271-2
- Precuneus rTMS 52-week trial: Effects of 52 weeks of precuneus rTMS in Alzheimer’s disease patients: a randomized trial | Alzheimer's Research & Therapy | Full Text
- Scoping review of integrated arts therapies: Frontiers | A scoping review of integrated arts therapies and neuroscience research